Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Pre-eclampsia classification

Introduction

Overview

Overview

In the new classification, proteinuria is not the main indicator for diagnosis of preeclampsia.The percentage of false-negative proteinuria, especially on the dipstick, is high. Preeclampsia may be classified according to the time of event into two groups: Early (preeclampsia before 34 weeks of gestation) and Late (preeclampsia after delivery). Preeclampsia with severe feature includes the following characteristics: systolic blood pressure β‰₯ 160 mmHg, diastolic blood pressure β‰₯ 110 mmHg, in two occasions apart 4 hours, thrombocytopnea (platelet count <100,000/dl), pulmonary edema, new-onset headache unresponsive to medications, visual disturbances, liver enzyme level > 2 times upper limit normal concentrations or persistent epigastric or right upper quadrant pain, and serum creatinine >1.1 mg/dl or doubling serum creatinine level in the absent of other causes of renal insufficiency.

Classification

Classification

  • The percentage of false-negative proteinuria especially on the dipstick is high. It is not the main criteria for the diagnosis of preeclampsia.
  • Preeclampsia may be classified according to the time of event into two groups:
  • Preeclampsia with severe feature includes the following characteristics:

Abbreviations: ALT: alanine aminotransferaseΒ ; AST:Aspartate aminotransferaseΒ ;ISSHP:International Society for the Study of Hypertension in Pregnancy; ACOG:American College of Obstetricians and Gynecologists

ISSHP 2001/ACOG 2002 ISSHP 2018 ACOG 2013 ACOG 2018
❑ New onset of hypertension (blood pressure β‰₯140 mmHg systolic and/or β‰₯90 mmHg diastolic) after 20 weeks of gestation and
❑ proteinuria (urine protein/creatinine β‰₯30 mg/mmol (0.3 mg/mg)or β‰₯300 mg/day or at least (β€˜1+’) on dipstick testing
❑ New onset of hypertension

(blood pressure of β‰₯140 mmHg systolic and/or β‰₯90 mmHg diastolic) after 20 weeks of gestation accompanied by one or more of the following:
❑ Proteinuria
❑ Maternal organ dysfunction including:
❑ Renal insufficiency (creatinine > 90 ΞΌmol/L; 1 mg/dL)
❑ Liver involvement (elevated transaminases with or without right upper quadrant or epigastric or abdominal pain)
❑ Neurological complications in eclampsia (altered mental status, blindness, stroke,hyperreflexia with clonus, severe headaches with hyperreflexia, persistent visual scotomata) )
❑ Hematological complications (thrombocytopenia with platelet count below 150,000/dL, DIC, hemolysis

❑ New onset of hypertension (blood pressure of β‰₯140 mmHg systolic and/or β‰₯90 mmHg diastolic) after 20 weeks of gestation on two occasions at least 4 hours apart accompanied by one or more of the following:
❑ Proteinuria
❑ Maternal organ dysfunction including:
❑ Renal insufficiency (serum creatinine> 1.1 mg/dL)
❑ Impaired liver function (ALA or ASA β‰₯ 70 U/l)
❑ Cerebral or visual symptoms
❑ Thrombocytopenia (platelet count < 100,000/dL
❑ Pulmonary edema
❑ Systolic blood pressure of 140 mm Hg or more or diastolic blood pressure of 90 mm Hg or more on two occasions at least 4 hours apart after 20 weeks of gestation in a woman with a previously normal blood pressure
❑ Systolic blood pressure of 160 mm Hg or more or diastolic blood pressure of 110 mm Hg or more
❑ And
❑Proteinuria
❑ 300 mg or more per 24 hour urine collection
❑ Protein/creatinine ratio of 0.3 mg/dL or more or Dipstick of 2+
❑ Or in the absence of proteinuria, new-onset hypertension with the new onset of any of the following:
❑ Thrombocytopenia (Platelet count less than

100,000/dl
❑ Renal insufficiency( Serum creatinine>1.1 mg/dL or a doubling of the serum creatinine concentration in the absence of other renal disease)
❑ Impaired liver function (Elevated blood level of liver transaminases to twice normal level)
❑ Pulmonary edema
❑ New-onset headache unresponsive to medication and not accounted for by alternative diagnoses or visual symptoms

References

References

  1. ↑ “Gestational Hypertension and Preeclampsia”. Obstetrics & Gynecology. 135 (6): e237–e260. 2020. doi:10.1097/AOG.0000000000003891. ISSNΒ 0029-7844.
  2. ↑ Woelkers, Doug; Barton, John; Dadelszen, Peter von; Sibai, Baha (2015). “[71-OR]”. Pregnancy Hypertension: An International Journal of Women’s Cardiovascular Health. 5 (1): 38. doi:10.1016/j.preghy.2014.10.075. ISSNΒ 2210-7789.
  3. ↑ Brown, Mark A.; Lindheimer, Marshall D.; Swiet, Michael de; Assche, Andre Van; Moutquin, Jean-Marie (2001). “THE CLASSIFICATION AND DIAGNOSIS OF THE HYPERTENSIVE DISORDERS OF PREGNANCY: STATEMENT FROM THE INTERNATIONAL SOCIETY FOR THE STUDY OF HYPERTENSION IN PREGNANCY (ISSHP)”. Hypertension in Pregnancy. 20 (1): ix–xiv. doi:10.1081/PRG-100104165. ISSNΒ 1064-1955.
  4. ↑ 4.0 4.1 Brown, Mark A.; Magee, Laura A.; Kenny, Louise C.; Karumanchi, S. Ananth; McCarthy, Fergus P.; Saito, Shigeru; Hall, David R.; Warren, Charlotte E.; Adoyi, Gloria; Ishaku, Salisu (2018). “Hypertensive Disorders of Pregnancy”. Hypertension. 72 (1): 24–43. doi:10.1161/HYPERTENSIONAHA.117.10803. ISSNΒ 0194-911X.
  5. ↑ Grill, Simon; Rusterholz, Corinne; Zanetti-DΓ€llenbach, Rosanna; Tercanli, Sevgi; Holzgreve, Wolfgang; Hahn, Sinuhe; Lapaire, Olav (2009). “Potential markers of preeclampsia – a review”. Reproductive Biology and Endocrinology. 7 (1): 70. doi:10.1186/1477-7827-7-70. ISSNΒ 1477-7827.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2]